Key result
Thromboangiitis obliterans patients show similar tobacco dependence compared to controls with CAD.
Why the study?
Expert opinion differed regarding the degree of tobacco dependence in patients with thromboangiitis obliterans compared to those with coronary artery disease.
Do subjects with thromboangiitis obliterans have a greater degree of tobacco dependence than subjects with coronary artery disease?
Case-Control (n=561)
Do subjects with thromboangiitis obliterans have a greater degree of tobacco dependence than subjects with coronary artery disease?
Absolute Event Rate: 4.7% vs 5.1%
p-value: p=0.24
Contrary to prior case reports and expert opinion, patients with thromboangiitis obliterans do not exhibit a greater degree of tobacco dependence than patients with coronary artery disease.
Challenges prior assumptions of greater tobacco dependence in thromboangiitis obliterans; leaves open alternative susceptibility factors for prospective study.
Thromboangiitis obliterans (TAO) is often cited as an extreme phenotype of vasculopathy and tobacco dependence. Although tobacco exposure is essential to progression of arterial ischemia in TAO, expert opinion differs regarding the degree of tobacco dependence in this population. The authors designed a prospective, case-control study to test the hypothesis that subjects with TAO have a greater degree of tobacco dependence than control subjects with coronary atherosclerosis (coronary artery disease [CAD]) do. Subjects with TAO (n = 218, confirmed by angiography, biopsy, or noninvasive arterial testing) or CAD (n = 343, diagnosed by coronary angiography) were mailed a standardized questionnaire regarding tobacco use, to which 103 and 273 responded, respectively. The degree of tobacco dependence in each group was ascertained by several methods, including the Fagerström Test for Nicotine Dependence Questionnaire. The TAO group was younger at index date (year of first diagnosis for TAO patients, year of percutaneous transluminal coronary angioplasty [PTCA] for CAD patients) (TAO 37.6+/-9.0 vs CAD 43.3+/-4.9 yr, p < 0.0001), but the groups did not differ in age at first tobacco exposure (TAO 16.7+/-3.1 vs CAD 17.3+/-4.2 yr, p = 0.67), current tobacco use at time of survey (TAO 54% vs CAD 46%, p = 0.17), or Fagerström score (TAO 4.7+/-2.3 vs CAD 5.1+/-2.3, p = 0.24). Kaplan-Meier curves showed no significant difference in time to topping tobacco use after first diagnosis (p = 0.076). TAO subjects smoked fewer cigarettes per day than CAD subjects (TAO 22.3+/-10.7 vs CAD 27.7+/-15.3 cigarettes/day, p = 0.003). Among current smokers (n = 170), TAO subjects also smoked fewer cigarettes/day (20.2+/-8.2 vs 24.6+/-12.7, p = 0.03), and were more likely to have made a serious attempt to stop (97% vs 90%, p = 0.03). In contrast to case reports of extreme tobacco dependence in the TAO population, the degree of tobacco dependence in subjects with TAO is similar to that in subjects with CAD.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2006) conducted a case-control in Thromboangiitis obliterans (Buerger's Disease) (n=561). Thromboangiitis obliterans vs. Coronary artery disease was evaluated on Fagerström score for nicotine dependence (p=0.24). Subjects with thromboangiitis obliterans had a similar degree of tobacco dependence (Fagerström score 4.7 vs 5.1, p=0.24) compared to control subjects with coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: